Business Description
Active Biotech AB
ISIN : SE0001137985
Compare
Compare
Traded in other countries / regions
ACTI.SwedenBTPC.Germany0GQU.UK IPO Date
2003-12-19Description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.97 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 2.7 | |||||
| 3-Year EPS without NRI Growth Rate | 2.2 | |||||
| 3-Year FCF Growth Rate | 2.8 | |||||
| 3-Year Book Growth Rate | -16.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.82 | |||||
| 9-Day RSI | 39.05 | |||||
| 14-Day RSI | 43.08 | |||||
| 6-1 Month Momentum % | -14.9 | |||||
| 12-1 Month Momentum % | -38.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.73 | |||||
| Quick Ratio | 3.73 | |||||
| Cash Ratio | 3.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.7 | |||||
| Shareholder Yield % | 0.76 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -225.89 | |||||
| ROA % | -132.02 | |||||
| ROIC % | -304.33 | |||||
| ROC (Joel Greenblatt) % | -841.83 | |||||
| ROCE % | -190.82 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.38 | |||||
| Price-to-Tangible-Book | 3.59 | |||||
| EV-to-EBIT | -3.59 | |||||
| EV-to-EBITDA | -3.59 | |||||
| EV-to-FCF | -3.59 | |||||
| Earnings Yield (Greenblatt) % | -27.86 | |||||
| FCF Yield % | -23.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Active Biotech AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.014 | ||
| Beta | 0.61 | ||
| Volatility % | 103.56 | ||
| 14-Day RSI | 43.08 | ||
| 14-Day ATR (€) | 0.002621 | ||
| 20-Day SMA (€) | 0.04109 | ||
| 12-1 Month Momentum % | -38.8 | ||
| 52-Week Range (€) | 0.0294 - 0.1288 | ||
| Shares Outstanding (Mil) | 361.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Active Biotech AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Active Biotech AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Active Biotech AB Frequently Asked Questions
What is Active Biotech AB(FRA:BTPC)'s stock price today?
The current price of FRA:BTPC is €0.04. The 52 week high of FRA:BTPC is €0.13 and 52 week low is €0.03.
When is next earnings date of Active Biotech AB(FRA:BTPC)?
The next earnings date of Active Biotech AB(FRA:BTPC) is 2024-05-03 Est..
Does Active Biotech AB(FRA:BTPC) pay dividends? If so, how much?
Active Biotech AB(FRA:BTPC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers